Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jochen Karow"'
Autor:
Jochen Karow, Georg Maschmeyer, Andrea Schumacher, Torsten Haferlach, Eva Lengfelder, Axel Heyll, Herbert Rasche, Maria-Cristina Sauerland, Norbert Frickhofen, Andreas Grüneisen, Claudia Schoch, Wolfgang E. Berdel, Carlo Aul, Wolf-Dieter Ludwig, Leopold Balleisen, Hartmut Eimermacher, Helmut Löffler, Wolfgang Hiddemann, Peter Staib, Bernhard Wörmann, T. Büchner, Wolf-Dietrich Hirschmann
Publikováno v:
Reviews in Clinical and Experimental Hematology. 6:46-59
Undertreatment of older patients with acute myeloid leukemia (AML) can explain, in part, their inferior outcome when compared to that of younger patients. In agreement with the benefit seen by patients under age 60 from high-dose cytosine arabinoside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e37acd315a8300cfbef6a4932d877a83
https://doi.org/10.1046/j.1468-0734.2002.00059.x
https://doi.org/10.1046/j.1468-0734.2002.00059.x
Autor:
Christian Wuchter, W. Gassmann, Uschi Kubica, Thomas Buchner, Maria Cristina Sauerland, H. Löffler, Eva Lengfelder, Wolf-Dieter Ludwig, L. Balleisen, Peter Staib, Brigitte Schlegelberger, Jochen Karow, Christa Fonatsch, Wolfgang Hiddemann, Susanne Schnittger, Achim Heinecke, Bernhard Wörmann, Detlef Haase, Andreas Grüneisen, Hartmut Eimermacher, Carlo Aul, Torsten Haferlach, Albrecht Reichle, Claudia Schoch, Wolfgang Kern
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 21(2)
Purpose: On the basis of cytomorphology according to the French-American-British (FAB) classification, we evaluated the prognostic impact of dysplastic features and other parameters in de novo acute myeloid leukemia (AML). We also assessed the clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74deb54436f1983e2a9af547722b0418
https://pubmed.ncbi.nlm.nih.gov/12885828
https://pubmed.ncbi.nlm.nih.gov/12885828